sur BERLANDES
BERLANDES Introduces PCCIDINCT2™ Ovarian Capsules
HANGZHOU, CHINA - BERLANDES, a leader in cellular regeneration and biotechnology, has launched the PCCIDINCT2™ Ovarian Capsules. This innovative product aims to enhance ovarian health and tackle reproductive issues in women, supported by extensive research in biological sciences.
The capsules have been developed with cutting-edge technology and nanobiotechnology to repair cellular damage from the surface to the nucleus. The product's unique formula, created by Stephen John Williams BUSBY and his team, includes antioxidant ingredients, inositol with vitamin B9, and Neumentix™ Spearmint extract to support hormone balance, emotional well-being, and ovarian rejuvenation.
These capsules address symptoms like irregular cycles, lifestyle imbalances, fertility issues, and menopause signs. This launch represents a significant step for BERLANDES in its mission to advance women’s health worldwide.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BERLANDES